Botanix Pharmaceuticals   Report issue

For profit Phase 2
Founded: Perth Australia (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2018
NCT03573518
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Botanix Pharmaceuticals

Active Ingredients

Drugs in Phase 2 Trials (2)

btx 1204 (1 trial)

cannabidiol (Epidiolex) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Dermatitis (Phase 2)

Dermatitis, Atopic (Phase 2)

Eczema (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2